# Yelena Drexler

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yelena-drexler/

## Facts

| Field | Value |
| --- | --- |
| Citations | 895 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 13 |
| i10-index | 15 |
| Last Known Institution | University of Miami |
| OpenAlex ID | https://openalex.org/A5006908260 |
| ORCID iD | 0000-0001-8563-4608 |
| Works | 44 |

## Researcher papers

- [Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-sparsentan-versus-irbesartan-in-patients-with-iga/)
- [Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial](https://scholariq.org/papers/sparsentan-in-patients-with-iga-nephropathy-a-prespecified-interim-analysis-from/)
- [Sterol-O-acyltransferase-1 has a role in kidney disease associated with diabetes and Alport syndrome](https://scholariq.org/papers/sterol-o-acyltransferase-1-has-a-role-in-kidney-disease-associated-with-diabetes/)
- [Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases](https://scholariq.org/papers/sphingosine-1-phosphate-metabolism-and-signaling-in-kidney-diseases/)
- [Novel Therapies for Alport Syndrome](https://scholariq.org/papers/novel-therapies-for-alport-syndrome/)
- [Management of Lupus Nephritis: New Treatments and Updated Guidelines](https://scholariq.org/papers/management-of-lupus-nephritis-new-treatments-and-updated-guidelines/)
- [Role of Sphingolipid Signaling in Glomerular Diseases: Focus on DKD and FSGS](https://scholariq.org/papers/role-of-sphingolipid-signaling-in-glomerular-diseases-focus-on-dkd-and-fsgs/)
- [Definition, identification and treatment of resistant hypertension in chronic kidney disease patients](https://scholariq.org/papers/definition-identification-and-treatment-of-resistant-hypertension-in-chronic/)
- [Aldosterone Blockade in Chronic Kidney Disease](https://scholariq.org/papers/aldosterone-blockade-in-chronic-kidney-disease/)
- [Associations of sodium and potassium intake with chronic kidney disease in a prospective cohort study: findings from the Hispanic Community Health Study/Study of Latinos, 2008–2017](https://scholariq.org/papers/associations-of-sodium-and-potassium-intake-with-chronic-kidney-disease-in-a/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Cardiovascular Health and Risk Factors](https://scholariq.org/topics/cardiovascular-health-and-risk-factors/)

## Researcher university

- [University of Miami](https://scholariq.org/institutions/university-of-miami/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.